Related Experiment Video
Updated: Jul 12, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Effects of prenatal opioid exposure on infant sympathetic and parasympathetic nervous system activity
Alexandra R Tabachnick1, Rina Das Eiden2, Madelyn H Labella3
1Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
Insights
Prenatal opioid exposure impacts infant autonomic nervous system (ANS) function at six months. Opioid agonist therapy (OAT) and other opioids show unique effects on ANS regulation, influencing stress response development.
Area of Science:
- Neuroscience
- Developmental Psychology
- Pediatrics
Background:
- Prenatal opioid exposure is linked to infant developmental issues, including autonomic nervous system (ANS) dysregulation.
- Limited research exists on long-term ANS effects beyond early infancy, considering both sympathetic and parasympathetic branches, and co-exposures.
Purpose of the Study:
- To investigate the effects of prenatal opioid agonist therapy (OAT) and other opioid exposures on infant ANS activity.
- To assess ANS responses at rest and during a social stressor (Still-Face Paradigm) at six months of age.
Main Methods:
- Studied 86 infants with varying prenatal opioid and substance exposures.
- Measured infant autonomic nervous system activity using physiological markers.
- Utilized the Still-Face Paradigm to elicit a social stress response.
Main Results:
- Prenatal exposure to OAT and other opioids demonstrated distinct impacts on infant ANS activity.
- Effects varied based on opioid subtype (methadone vs. buprenorphine) and gestational timing.
- Observed differences in ANS regulation at rest and during the social stressor.
Conclusions:
- Prenatal opioid exposure has lasting, specific effects on infant autonomic nervous system development.
- Understanding these effects is crucial for addressing developmental challenges in affected infants.
- Findings inform models of the developing infant stress response system.
Abstract:
Prenatal opioid exposure has been associated with developmental problems, including autonomic nervous system dysregulation. However, little is known about the effects of prenatal opioid exposure on the autonomic nervous system beyond the first days of life, particularly across both the parasympathetic and sympathetic branches, and when accounting for exposure to other substances. The present study examined the effects of prenatal exposure to opioid agonist therapy (OAT, e.g., methadone) and other opioids on infant autonomic nervous system activity at rest and in response to a social stressor (the Still-Face Paradigm) at six months among 86 infants varying in prenatal opioid and other substance exposure. Results indicated that OAT and other opioids have unique effects on the developing autonomic nervous system that may further depend on subtype (i.e., methadone versus buprenorphine) and timing in gestation. Results are discussed in the context of theoretical models of the developing stress response system.
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Teratogenicity

